Company Filing History:
Years Active: 2010-2011
Title: Laure Allard: Innovator in Diagnostic Methods
Introduction
Laure Allard is a prominent inventor based in Gaillard, France. She has made significant contributions to the field of diagnostics, particularly in relation to brain damage and stroke. With a total of 2 patents, her work is paving the way for advancements in medical diagnostics.
Latest Patents
Laure Allard's latest patents include a diagnostic method for brain damage-related disorders. This method involves detecting specific polypeptides in a sample of body fluid taken from the subject. The polypeptides include A-FABP, E-FABP, PGP 9.5, GFAP, Prostaglandin D synthase, Neuromodulin, Neurofilament L, Calcyphosine, RNA binding regulatory subunit, Ubiquitin fusion degradation protein 1 homolog, Nucleoside diphosphate kinase A, Glutathione S transferase P, Cathepsin D, DJ-1 protein, Peroxiredoxin 5, and Peptidyl-prolyl cis-trans isomerase A (Cyclophilin A). Additionally, she has developed a diagnostic method for stroke, which determines the concentration of polypeptides such as Apo C-III, Serum Amyloid A, Apo C-I, Antithrombin III fragment, and Apo A-I in a sample of body fluid.
Career Highlights
Laure Allard is currently employed at Electrophoretics Limited, where she continues to innovate in the field of diagnostics. Her work is characterized by a commitment to improving diagnostic accuracy and patient outcomes.
Collaborations
Laure collaborates with notable colleagues, including Pierre Lescuyer and Denis Francois Hochstrasser. Their combined expertise enhances the research and development efforts at Electrophoretics Limited.
Conclusion
Laure Allard is a trailblazer in the field of diagnostic methods, with her innovative patents contributing to significant advancements in medical science. Her dedication to improving diagnostic techniques is evident in her work and collaborations.